A post-licensure evaluation of the safety of inactivated hepatitis A vaccine (VAQTA, Merck) in children and adults (Q47245555)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	A post-licensure evaluation of the safety of inactivated hepatitis A vaccine (VAQTA, Merck) in children and adults	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14741171

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/14741171

title

A post-licensure evaluation of the safety of inactivated hepatitis A vaccine (VAQTA, Merck) in children and adults (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14741171

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/14741171

main subject

hepatitis A

1 reference

based on heuristic

inferred from title

hepatitis A vaccine

1 reference

based on heuristic

inferred from title

author

Paul M. Coplan

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14741171

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/14741171

author name string

Steven Black

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14741171

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/14741171

Henry Shinefield

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14741171

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/14741171

John Hansen

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14741171

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/14741171

Edwin Lewis

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14741171

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/14741171

Ling Su

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14741171

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/14741171

language of work or name

English

0 references

publication date

1 January 2004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14741171

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/14741171

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14741171

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/14741171

volume

22

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14741171

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/14741171

issue

5-6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14741171

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/14741171

page(s)

766-772

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14741171

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/14741171

cites work

Type A viral hepatitis. New developments in an old disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.034

retrieved

7 January 2021

Hepatitis A virus infection in households

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.034

retrieved

7 January 2021

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.034

retrieved

7 January 2021

Postmarketing evaluation of the safety and effectiveness of varicella vaccine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.034

retrieved

7 January 2021

Postlicensure surveillance for Haemophilus influenzae type b invasive disease after use of Haemophilus influenzae type b oligosaccharide CRM197 conjugate vaccine in a large defined United States population: a four-year eight-month follow-up.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.034

retrieved

7 January 2021

Identifiers

DOI

10.1016/J.VACCINE.2003.08.034

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14741171

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/14741171

PubMed publication ID

14741171

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14741171

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/14741171

ResearchGate publication ID

8905106

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47245555&oldid=2147760013"